These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22149435)

  • 1. Urothelial cancers: using biology to improve outcomes.
    Pezaro C; Liew MS; Davis ID
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):87-98. PubMed ID: 22149435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
    Pollera CF; Nelli F
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy in the treatment of advanced urothelial tumors].
    Sternberg CN
    Urologe A; 1991 Jan; 30(1):33-44. PubMed ID: 2014585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
    Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights in intravesical treatment for intermediate- and high-risk non-muscle-invasive urothelial bladder carcinoma.
    Babjuk M
    Eur Urol; 2010 May; 57(5):774-6; author reply 776-7. PubMed ID: 20080332
    [No Abstract]   [Full Text] [Related]  

  • 8. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of targeted therapy in metastatic transitional cell carcinoma of the bladder.
    Sadeghi S; Garcia JA
    Semin Oncol; 2012 Oct; 39(5):608-14. PubMed ID: 23040257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology and targeted therapies for urothelial carcinoma.
    Seront E; Machiels JP
    Cancer Treat Rev; 2015 Apr; 41(4):341-53. PubMed ID: 25828962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic chemotherapy for advanced bladder cancer: update and controversies.
    Garcia JA; Dreicer R
    J Clin Oncol; 2006 Dec; 24(35):5545-51. PubMed ID: 17158540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.
    Galsky MD; Hendricks R; Svatek R; Bangs R; Hoffman-Censits J; Clement J; Dreicer R; Guancial E; Hahn N; Lerner SP; O'Donnell PH; Quale DZ; Siefker-Radtke A; Shipley W; Sonpavde G; Vaena D; Vinson J; Rosenberg J
    Cancer; 2013 Jun; 119(11):1994-8. PubMed ID: 23456777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
    Sternberg CN; Yagoda A; Scher HI
    Prog Clin Biol Res; 1988; 277():45-51. PubMed ID: 3054909
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
    Pectasides D; Pectasides M; Economopoulos T
    Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.
    Pectasides D; Pectasides M; Nikolaou M
    Eur Urol; 2005 Jul; 48(1):60-7; discussion 67-8. PubMed ID: 15967253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
    Rosenberg JE
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1729-36. PubMed ID: 18062747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of superficial and muscle-invasive urothelial cancers of the bladder.
    Resnick MJ; Bassett JC; Clark PE
    Curr Opin Oncol; 2013 May; 25(3):281-8. PubMed ID: 23425709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.
    Ahmed HU; Arya M; Patel HR
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1011-22. PubMed ID: 16336092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.